ood morning, everyone, and how are you today? A bright and shiny sun is enveloping the Pharmalot campus, where the snow is piled high and the shortest of short people is sleeping in. As for us, we are considering our to-do list and brewing a needed cup of stimulation, since we anticipate another busy day. No doubt, you can relate. So time to get cracking. Here are some items of interest to get you started. Have a wonderful day and drop us a line when something interesting arises …

The health insurance giant Cigna (CI) agreed to buy the pharmacy benefit manager Express Scripts (ESRX) for $67 billion in cash and stock, including the assumption of $15 billion in debt, The New York Times reports. The transaction adds to a string of deals in the health care sector as insurers and others seek to control costs and stave off a possible challenge from Amazon. Express Scripts is the largest pharmacy benefit manager in the U.S., responsible for the drug plans of more than 80 million Americans, including on behalf of such large employers as the Department of Defense.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Hmmm – is there a link here? “… several drug makers have been eliminating jobs in recent months. Among them are Allergan, Pfizer, and Teva Pharmaceuticals, which is undergoing a massive reorganization.”

    All rotate around the failed attempt to save PFE tax $ … and so the employees pay the price for management errors. And the new tax law made it unnecessary ….. sad indeed.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.